Kewaunee Scientific Reports Growth in Sales but Faces Profitability Challenges in Q3 2025

Kewaunee Scientific Corporation (NASDAQ: KEQU) has recently released its financials for the three and nine months ended January 31, 2025, highlighting both growth and challenges.

**Key Financial Highlights:**

• Net Sales: $67.17 million for Q3 2025, up from $46.78 million in Q3 2024. For the nine months, net sales increased to $163.32 million from $147.05 million year-over-year.
• Gross Profit: Increased to $18.38 million (27.4% gross margin) for Q3 2025 from $12.03 million (25.7% gross margin) in Q3 2024. Gross profit for nine months was $44.82 million (27.4% margin) vs. $37.41 million (25.4% margin) in the prior year.
• Operating Expenses: Grew to $16.13 million (24.0% of sales) compared to $8.22 million (17.6% of sales) in Q3 2024 and rose to $35.56 million (21.8% of sales) for nine months from $24.69 million (16.8% of sales).
• Net Earnings: Declined to $1.35 million ($0.45 per diluted share) in Q3 2025 from $2.52 million ($0.85 per diluted share) in Q3 2024. Total net earnings for the nine months were $6.56 million ($2.20 per diluted share) down from $7.73 million ($2.64 per diluted share).

**Positive Aspects:**

• Strong revenue growth driven by the acquisition of Nu Aire, which closed on November 1, 2024, contributing significantly to Domestic sales.
• Improved gross profits and margins, showcasing enhanced manufacturing productivity and effective cost control measures.
• Substantial order backlog of $221.6 million as of January 31, 2025, indicating strong future sales potential.

**Negative Aspects:**

• Operating expenses increased significantly, impacting overall profitability, primarily due to the Nu Aire acquisition costs and higher consulting fees.
• Drop in net earnings and earnings per share which raises concerns about sustainability in profitability amidst rising expenses and interest costs.
• International sales facing challenges, particularly in India, resulting in lower growth in that segment.

**Strategic Moves:**

• Completed acquisition of Nu Aire for $55 million aimed at expanding product offerings in laboratory environments.
• Adjusted share repurchase program to allow additional buybacks, reflecting management's confidence in the company's stock value.

The financial results reflect both the potential and the challenges ahead for Kewaunee Scientific Corporation. The growing revenue from domestic operations suggests a positive trend, while the increase in operating expenses and decreases in international sales signal areas requiring attention.